-
Ibuprofen in the first three months of pregnancy may harm future fertility
europeanpharmaceuticalreview
April 29, 2019
Researchers have found evidence in human ovarian tissue that exposure to ibuprofen during the first three months of foetal development results in a dramatic loss of the germ cells…
-
Lab-on-a-chip for tracking single bacterial cells
europeanpharmaceuticalreview
April 29, 2019
Researchers have set up a lab-on-a-chip with accompanying automatic analysis software to study gene regulation in single bacterial cells…
-
Measuring molecular interactions using LiP-mass spectrometric analysis
europeanpharmaceuticalreview
April 29, 2019
Researchers have systematically analysed and quantified the interactions of all proteins with metabolites on the level of the whole proteome…
-
Robotic method isolates high-producing cell lines for HIV vaccine production
europeanpharmaceuticalreview
April 29, 2019
Technical advances in vaccine production should shorten the time to clinical trials, breaking the logjam of promising new candidate vaccines waiting to be tested…
-
Precigen Opens Gene and Cell Therapy Manufacturing Facility in Germantown, Maryland
firstwordpharma
April 26, 2019
GERMANTOWN, Md., April 25, 2019 /PRNewswire/ -- Precigen, Inc., a wholly-owned subsidiary of Intrexon Corporation (NASDAQ: XON) and ...
-
Scientists design new skin cell culture technique to study HPV
europeanpharmaceuticalreview
April 25, 2019
Novel approach enables genetic analysis of entire viral life cycle, starting with initial infection…
-
FDA expands Keytruda label to include stage 3 and 4 non-small cell lung cancer
pharmafile
April 23, 2019
MSD has revealed that its anti-PD-1 therapy Keytruda (pembrolizumab) has received expanded indication from the FDA to include the first-line treatment of stage 3 or metastatic non-small cell lung cancer (NSCLC).
-
Celonic AG Appoints Soenke Brunswieck as Vice President Cell & Gene Therapy
b3cnewswire
April 23, 2019
Celonic AG Appoints Soenke Brunswieck as Vice President Cell & Gene Therapy.
-
Mouse model shows success of senolytic drugs in reversing senescent cell damage
europeanpharmaceuticalreview
April 22, 2019
An NIH-funded study has demonstrated that a combination of senolytic drugs can successfully reverse cell senescence in mice...
-
Stem cells to grow new immune system in Crohn’s disease patients
europeanpharmaceuticalreview
April 22, 2019
A phase III clinical trial looks to use a patients own stem cells to treat the debilitating disease…